Company has received distributionship rights.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shukra Pharmaceuticals has signed a distributorship deal with Seraseal Medical Pvt Ltd to distribute Seraseal's medical devices and surgical instruments across India. The arrangement covers three key channels: government medical supply corporations in Uttar Pradesh (UPMSCL) and Gujarat (GMSCL), and all defence institutions and hospitals across India. Shukra will quote and participate in tenders, collect orders, and execute supplies on Seraseal's behalf. The company describes this as part of its strategy to diversify into the growing medical devices market and expects it to contribute meaningfully to revenue and growth. No financial terms, contract value, or revenue quantum have been disclosed.
This expands Shukra's distribution footprint into government healthcare and defence sectors, which could open up a steady, tender-based revenue stream, though the lack of disclosed financial terms makes it hard to gauge near-term impact on the stock.